These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12486439)

  • 1. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study.
    Krittayaphong R; Bhuripanyo K; Punlee K; Kangkagate C; Chaithiraphan S
    Am Heart J; 2002 Dec; 144(6):e10. PubMed ID: 12486439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease.
    Krittayaphong R; Bhuripanyo K; Raungratanaamporn O; Sriratanasathavorn C; Punlee K; Kangkagate C; Cheumsuk W; Chaithiraphan S
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S124-9. PubMed ID: 11194002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atenolol in the treatment of premature ventricular contractions. A double blind study in 68 patients (author's transl)].
    Körst HA; Brandes JW; Lembcke HJ; Littmann KP
    Z Kardiol; 1981 May; 70(5):419-24. PubMed ID: 6168124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
    Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F
    Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of atenolol in patients with dilated cardiomyopathy.
    Krittayaphong R; Mahanonda N; Kangkagate C; Phankingthongkum R; Chaithiraphan S
    J Med Assoc Thai; 1998 Mar; 81(3):201-7. PubMed ID: 9623012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease.
    Takemoto M; Yoshimura H; Ohba Y; Matsumoto Y; Yamamoto U; Mohri M; Yamamoto H; Origuchi H
    J Am Coll Cardiol; 2005 Apr; 45(8):1259-65. PubMed ID: 15837259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depression of diurnal dispersion of sinus rhythm in patients after myocardial infarct].
    Kaliuzhin VV; Tepliakov AT; Maleeva MA; Pushnikova EIu; Solovtsov MA
    Ter Arkh; 2000; 72(9):44-7. PubMed ID: 11076416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
    Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease.
    Tan JH; Scheinman MM
    Am J Cardiol; 2008 Apr; 101(8):1142-6. PubMed ID: 18394448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of radiofrequency catheter ablation of right ventricular outflow tract tachycardia using the CARTO system.
    Pruszkowska-Skrzep P; Kalarus Z; Sredniawa B; Lenarczyk R; Kowalski O; Musialik-Łydka A; Stabryła-Deska J; Prokopczuk J; Sliwińska A
    Kardiol Pol; 2005 Feb; 62(2):138-44. PubMed ID: 15815797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.